Additionally, a study by the AIDS-Malignancies Consortium Trial 010, a phase 3 trial of CHOP vs R-CHOP in patients with HIV-associated NHL showed a better CR of 47% for CHOP [14] than was observed in our study (27%). Here, DDIT3 is linked to AIDS.